Breast Cancer Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults between 18 and 70 years old.
- People in the first group (Cohort 1): those who had radical surgery for breast cancer without receiving any treatment beforehand (such as chemotherapy or radiation).
- People in the second group (Cohort 2): those first diagnosed with invasive breast cancer that had spread to the lymph nodes under the arm, and who are willing to have radical surgery after completing their current treatment.
- People from whom blood plasma samples can be collected during their treatment.
- People who are willing to sign a consent form agreeing to take part in the trial.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are pregnant or breastfeeding.
- People who have already had their breast tumour surgically removed.
- People who have been diagnosed with another type of cancer in the 5 years before joining the trial.
- People who, in the year before joining the trial, had imaging scans suggesting another possible cancer that was never confirmed by a tissue test (biopsy or pathology).
- People whose scans suggest the cancer may have spread to distant parts of the body, or who have lymph node involvement that surgery would not be able to fully remove.
- People who have received any blood product transfusion or infusion in the 30 days before joining the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Negative predictive value (NPV) of the TuFEst-based classifier for predicting pathologic node-negative status (pN0)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.